JP2024517861A5 - - Google Patents
Info
- Publication number
- JP2024517861A5 JP2024517861A5 JP2023568277A JP2023568277A JP2024517861A5 JP 2024517861 A5 JP2024517861 A5 JP 2024517861A5 JP 2023568277 A JP2023568277 A JP 2023568277A JP 2023568277 A JP2023568277 A JP 2023568277A JP 2024517861 A5 JP2024517861 A5 JP 2024517861A5
- Authority
- JP
- Japan
- Prior art keywords
- stereoisomers
- stereoisomer
- pharmaceutically acceptable
- solvate
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB202106485 | 2021-05-06 | ||
| GB2106485.2 | 2021-05-06 | ||
| PCT/GB2022/051166 WO2022234298A1 (en) | 2021-05-06 | 2022-05-06 | Pkc-theta modulators |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024517861A JP2024517861A (ja) | 2024-04-23 |
| JP2024517861A5 true JP2024517861A5 (cg-RX-API-DMAC7.html) | 2025-12-01 |
| JP7871296B2 JP7871296B2 (ja) | 2026-06-08 |
Family
ID=82100190
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023568277A Active JP7871296B2 (ja) | 2021-05-06 | 2022-05-06 | PKC-θモジュレーター |
Country Status (14)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3214088A1 (en) * | 2021-05-06 | 2022-11-10 | Peter Ray | Pkc-theta modulators |
| WO2025235367A1 (en) * | 2024-05-06 | 2025-11-13 | D. E. Shaw Research, Llc | Azaindolinone compounds as kca3.1 potassium channel blockers |
| WO2025255298A1 (en) * | 2024-06-06 | 2025-12-11 | Bristol-Myers Squibb Company | Pkc-theta inhibitors, compositions, and methods of use |
| WO2025255292A1 (en) * | 2024-06-06 | 2025-12-11 | Bristol-Myers Squibb Company | Pkc-theta inhibitors, compositions, and methods of use |
| WO2025255288A1 (en) * | 2024-06-06 | 2025-12-11 | Bristol-Myers Squibb Company | Pkc-theta inhibitors, compositions, and methods of use |
| KR20260031910A (ko) * | 2024-08-30 | 2026-03-09 | 한국과학기술연구원 | 엑토뉴클레오티드 피로포스파타아제-포스포디에스터라아제의 저해 활성을 갖는 신규한 5,7-다이하이드로-6H-피롤로[2,3-d]피리미딘-6-온 유도체 및 이들의 용도 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8173635B2 (en) * | 2007-11-02 | 2012-05-08 | Vertex Pharmaceuticals Incorporated | Kinase inhibitors |
| CA2713864A1 (en) * | 2008-02-04 | 2009-08-13 | Cytokinetics, Incorporated | Certain chemical entities, compositions and methods |
| GB0920382D0 (en) | 2009-11-20 | 2010-01-06 | Univ Dundee | Design of molecules |
| AU2010352577A1 (en) * | 2010-05-05 | 2012-01-19 | Vertex Pharmaceuticals Incorporated | 4 substituted pyrazolopyrimidines useful as PKC-theta inhibitors |
| RU2016129380A (ru) | 2013-12-20 | 2018-01-25 | СИГНАЛ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи | Замещенные диаминопиримидильные соединения, их композиции и способы лечения с их участием |
| US9624170B2 (en) * | 2013-12-26 | 2017-04-18 | Takeda Pharmaceutical Company Limited | 4-(piperrazin-1-yl)-pyrrolidin-2-one compounds as monoacylglycerol lipase (MAGL) inhibitors |
| AU2017312970B2 (en) * | 2016-08-16 | 2021-08-12 | Merck Patent Gmbh | 2-oxo-imidazopyridines as reversible BTK inhibitors and uses thereof |
| EP3976612A4 (en) * | 2019-05-28 | 2023-04-26 | Mankind Pharma Ltd | NEW COMPOUNDS FOR INHIBITION OF JANUS KINASE 1 |
| CN112480116B (zh) * | 2019-09-11 | 2024-03-29 | 南京正大天晴制药有限公司 | Pkb抑制剂 |
| CA3214088A1 (en) * | 2021-05-06 | 2022-11-10 | Peter Ray | Pkc-theta modulators |
-
2022
- 2022-05-06 US US18/557,852 patent/US20240262821A1/en active Pending
- 2022-05-06 BR BR112023022706A patent/BR112023022706A2/pt unknown
- 2022-05-06 CN CN202280033078.6A patent/CN117355522A/zh active Pending
- 2022-05-06 CA CA3213703A patent/CA3213703A1/en active Pending
- 2022-05-06 KR KR1020237041625A patent/KR20240024062A/ko active Pending
- 2022-05-06 PE PE2023002993A patent/PE20240070A1/es unknown
- 2022-05-06 IL IL307665A patent/IL307665A/en unknown
- 2022-05-06 MX MX2023013013A patent/MX2023013013A/es unknown
- 2022-05-06 JP JP2023568277A patent/JP7871296B2/ja active Active
- 2022-05-06 EP EP22731281.6A patent/EP4333982A1/en active Pending
- 2022-05-06 WO PCT/GB2022/051166 patent/WO2022234298A1/en not_active Ceased
- 2022-05-06 AU AU2022269883A patent/AU2022269883A1/en active Pending
-
2023
- 2023-11-02 CO CONC2023/0014939A patent/CO2023014939A2/es unknown
- 2023-11-02 CL CL2023003246A patent/CL2023003246A1/es unknown
-
2025
- 2025-10-06 US US19/350,984 patent/US20260035367A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024518447A5 (cg-RX-API-DMAC7.html) | ||
| US9505737B2 (en) | Treprostinil derivative compounds and methods of using same | |
| RU2008144584A (ru) | 4,5-дигидро-[1,2,4]триазоло[4,3-f]птеридины в качестве ингибиторов протеинкиназы plk1 для лечения пролиферативных заболеваний | |
| JP2025071130A5 (cg-RX-API-DMAC7.html) | ||
| RU2430923C2 (ru) | Тиазолилдигидрохиназолины | |
| RU2012117398A (ru) | Бензоксазепиновые ингибиторы pi3 и способы применения | |
| JP2023550122A5 (cg-RX-API-DMAC7.html) | ||
| JP2021514373A5 (cg-RX-API-DMAC7.html) | ||
| RU2005110061A (ru) | Замещенные пиперазины, (1,4)-диазепины и 2,5-диазабицикло(2,2,1)гептаны в качестве н1-и/или н3-антагонистов гистамина или обратных н3-антагонистов гистамина | |
| JP2021523887A (ja) | XIIa因子インヒビター | |
| RU2012116877A (ru) | Соединения 2-пиридона, применяемые в качестве ингибиторов нейтрофильной эластазы | |
| JP2005538099A5 (cg-RX-API-DMAC7.html) | ||
| JP2006511552A5 (cg-RX-API-DMAC7.html) | ||
| JP2004517843A5 (cg-RX-API-DMAC7.html) | ||
| JP2021102643A5 (cg-RX-API-DMAC7.html) | ||
| JP2019502686A5 (cg-RX-API-DMAC7.html) | ||
| WO2021201201A1 (ja) | 新型コロナウイルス感染症(covid-19)の予防または治療剤および医薬組成物 | |
| WO2015002755A2 (en) | Compounds for the treatment of malaria | |
| RU2002105518A (ru) | Гетероциклические соединения, ингибирующие ангиогенез | |
| RU2015106013A (ru) | Соединения пиразолкарбоксамида, композиции и способы применения | |
| AU2011271480B2 (en) | Riminophenazines with 2-(heteroaryl)amino substituents and their anti-microbial activity | |
| JP2023522693A5 (cg-RX-API-DMAC7.html) | ||
| RU2011121511A (ru) | Гетероциклические антивирусные производные арилпиридона | |
| CA2345284A1 (en) | Blood pressure stabilization during hemodialysis | |
| EA200970444A1 (ru) | Способ введения противоопухолевого соединения |